Mechanisms of HCV survival in the host (Q37433774)

20 August 2017

1 reference

title

Mechanisms of HCV survival in the host (English)

1 reference

20 August 2017

Ella H Sklan

1

1 reference

20 August 2017

Prista Charuworn

series ordinal

2

1 reference

20 August 2017

Philip S Pang

series ordinal

3

1 reference

20 August 2017

Jeffrey S Glenn

series ordinal

4

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 April 2009

1 reference

Nature Reviews Gastroenterology & Hepatology

20 August 2017

1 reference

20 August 2017

6

1 reference

20 August 2017

4

1 reference

20 August 2017

217-227

1 reference

https://scigraph.springernature.com/pub.10.1038/nrgastro.2009.32

20 August 2017

0 references

cites work

Dynamics of Hepatitis C Virus Replication in Human Liver

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Effects of mutation in hepatitis C virus nonstructural protein 5A on interferon resistance mediated by inhibition of PKR kinase activity in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Infection and dysfunction of circulating blood dendritic cells and their subsets in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Pervasive influence of hepatitis C virus on the phenotype of antiviral CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Global burden of disease (GBD) for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Global epidemiology of hepatitis C virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Binding of hepatitis C virus to CD81

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Identification of scavenger receptor SR-BI as a high density lipoprotein receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Scavenger receptor BI: a scavenger receptor with a mission to transport high density lipoprotein lipids

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Serum amyloid A has antiviral activity against hepatitis C virus by inhibiting virus entry in a cell culture system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

An Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing Antibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Interferon alpha decreases expression of human scavenger receptor class BI, a possible HCV receptor in hepatocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Human occludin is a hepatitis C virus entry factor required for infection of mouse cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Mutations within the CD81-binding sites and hypervariable region 2 of the envelope 2 protein: correlation with treatment response in hepatitis C virus-infected patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Double-stranded RNA-activated protein kinase mediates virus-induced apoptosis: a new role for an old actor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Functional properties of a monoclonal antibody inhibiting the hepatitis C virus RNA-dependent RNA polymerase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Hepatitis C virus non-structural proteins in the probable membranous compartment function in viral genome replication

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Replication strategy of Kunjin virus: evidence for recycling role of replicative form RNA as template in semiconservative and asymmetric replication

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Quantitative Analysis of the Hepatitis C Virus Replication Complex

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Visualization of Double-Stranded RNA in Cells Supporting Hepatitis C Virus RNA Replication

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Complete replication of hepatitis C virus in cell culture

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Robust hepatitis C virus infection in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Cellular Determinants of Hepatitis C Virus Assembly, Maturation, Degradation, and Secretion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Nonstructural Protein Precursor NS4A/B from Hepatitis C Virus Alters Function and Ultrastructure of Host Secretory Apparatus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

TBC1D20 is a Rab1 GTPase-activating protein that mediates hepatitis C virus replication

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

A Rab-GAP TBC domain protein binds hepatitis C virus NS5A and mediates viral replication

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Gene regulation by transcription factors and microRNAs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Interferon modulation of cellular microRNAs as an antiviral mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Is RNA interference involved in intrinsic antiviral immunity in mammals?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Cellular cofactors affecting hepatitis C virus infection and replication

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Viral Determinants of Resistance to Treatment in Patients with Hepatitis C

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Evasion of intracellular host defence by hepatitis C virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Replication of hepatitis C virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Comparison between subgenomic replicons of hepatitis C virus genotypes 2a (JFH-1) and 1b (Con1 NK5.1).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Intracellular pattern recognition receptors in the host response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Interferon signaling and treatment outcome in chronic hepatitis C

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Lack of response to exogenous interferon-α in the liver of chimpanzees chronically infected with hepatitis C virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Activation of endoplasmic reticulum stress response by hepatitis viruses up-regulates protein phosphatase 2A.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Altered innate immunity in chronic hepatitis C infection: cause or effect?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Higher clearance of hepatitis C virus infection in females compared with males

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Polymorphisms in the IL-12B gene and outcome of HCV infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Host factors and failure of interferon-alpha treatment in hepatitis C virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Lack of Protective Immunity Against Reinfection with Hepatitis C Virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Presence of functional dendritic cells in patients chronically infected with hepatitis C virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Decrease and dysfunction of dendritic cells correlate with impaired hepatitis C virus-specific CD4+ T-cell proliferation in patients with hepatitis C virus infection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Myeloid dendritic cells of patients with chronic HCV infection induce proliferation of regulatory T lymphocytes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

The Neutralizing Activity of Anti-Hepatitis C Virus Antibodies Is Modulated by Specific Glycans on the E2 Envelope Protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

HCV core protein interaction with gC1q receptor inhibits Th1 differentiation of CD4+ T cells via suppression of dendritic cell IL-12 production

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Modulation of the peripheral T-Cell response by CD4 mutants of hepatitis C virus: transition from a Th1 to a Th2 response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Virological and immunological determinants of intrahepatic virus-specific CD8+ T-cell failure in chronic hepatitis C virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Hepatitis C virus mutation affects proteasomal epitope processing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Blocking of monocyte-associated B7-H1 (CD274) enhances HCV-specific T cell immunity in chronic hepatitis C infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Peripheral virus-specific T-cell interleukin-10 responses develop early in acute hepatitis C infection and become dominant in chronic hepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Identification and In Vitro Expansion of Functional Antigen-Specific CD25+ FoxP3+ Regulatory T Cells in Hepatitis C Virus Infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Compartmentalization of hepatitis C virus genotypes between plasma and peripheral blood mononuclear cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Compartmentalization of hepatitis C virus quasispecies in blood mononuclear cells of patients with mixed cryoglobulinemic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Activation and evasion of the antiviral 2'-5' oligoadenylate synthetase/ribonuclease L pathway by hepatitis C virus mRNA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Viral evolution and interferon resistance of hepatitis C virus RNA replication in a cell culture model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

IFN-alpha antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Regulation of PKR and IRF-1 during hepatitis C virus RNA replication

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.32

Internal initiation of translation in eukaryotes: the picornavirus paradigm and beyond

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19347013

12 December 2020

inferred from PubMed ID database lookup

Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19347013

12 December 2020

inferred from PubMed ID database lookup

Mutations in immunodominant T cell epitopes derived from the nonstructural 3 protein of hepatitis C virus have the potential for generating escape variants that may have important consequences for T cell recognition.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19347013

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/NRGASTRO.2009.32

1 reference

release_igvie2p4ivcdjoms4yfhfep5ve

20 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/igvie2p4ivcdjoms4yfhfep5ve

24 November 2022

mapped directly with Wikidata item

1 reference